Biography

Dr. Ramesh Kumar, Ph.D., is a biotechnology executive with over three decades of management experience in private and public companies. He co-founded Onconova Therapeutics, Inc. in 1998 and transitioned to an Advisory role in early 2019. Dr. Kumar served as the Chief Executive Officer of Onconova from 1998 to January 2019 and served as its President from 1998 to June 2018. He has held positions in R&D and management at Princeton University, Bristol-Myers Squibb, DNX (later Nextran, a subsidiary of Baxter) and Kimeragen (later Valigen), where he served as President of the Genomics and Transgenics Division. Dr. Kumar has authored over 50 publications spanning the areas of molecular oncology, transgenic animals, gene therapy and recombination. His is an inventor on more than 10 US Patents and a co-editor of the book “Molecular Basis of Human Cancer” published in 1993. Dr. Kumar received his Ph.D. in Molecular Biology from the University of Illinois, Chicago and trained at the National Cancer Institute.